AbbVie Inc.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psori…
Drug Manufacturers - General
US, North Chicago [HQ]
Ratios
15 Sheets · Starting from 2023Margins, Growth Rates In %
| Ratio | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||
| Gross Margin | 71.46 | 72.55 | 73.40 | 75.47 | 75.62 | 77.83 | 80.31 | 77.25 | 75.05 | 76.44 | 77.64 | 66.41 | 68.96 | 70.00 | 83.84 | |
| Profit Margin | 32.62 | 26.72 | 19.68 | 28.70 | 21.97 | 8.89 | 22.50 | 23.22 | 18.82 | 17.36 | 23.69 | 10.08 | 20.54 | 20.39 | 8.95 | |
| Operating Margin | 34.70 | 30.16 | 20.76 | 31.65 | 30.14 | 17.09 | 32.97 | 36.60 | 33.99 | 19.49 | 39.03 | 1.04 | 31.89 | 31.21 | 32.08 | |
|
EPS Growth
|
- - | -9.76 | -18.15 | 58.02 | -22.99 | -56.98 | 183.78 | 15.87 | -9.32 | 11.48 | 43.63 | -48.49 | 137.36 | 2.62 | -58.95 | |
| EPS USD | 287.00 | 259.00 | 212.00 | 335.00 | 258.00 | 111.00 | 315.00 | 365.00 | 331.00 | 369.00 | 530.00 | 273.00 | 648.00 | 665.00 | 273.00 | |
| Return on Assets (ROA) | - - | 19.77 | 17.47 | 19.53 | 14.14 | 6.44 | 9.70 | 9.01 | 7.50 | 9.58 | 8.84 | 3.07 | 7.88 | 8.53 | 3.61 | |
| Return on Equity (ROE) | - - | 26.61 | 28.09 | 156.85 | 91.90 | 101.84 | 130.39 | 128.41 | 104.16 | -67.33 | -96.45 | 35.30 | 74.91 | 68.60 | 46.94 | |
| Return on Invested Capital (ROIC) | - - | 25.95 | 27.72 | 28.16 | 22.82 | 15.25 | 16.38 | 17.08 | 15.52 | 21.92 | 20.74 | 0.65 | 17.31 | 19.77 | 19.48 | |
| Solvency | ||||||||||||||||
| Equity Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Debt/Assets | - - | - - | - - | 58.03 | 50.43 | 54.49 | 59.70 | 55.74 | 52.79 | 67.92 | 74.88 | 57.16 | 52.33 | 45.58 | 44.08 | |
| Debt/Equity | - - | - - | - - | 466.01 | 327.76 | 861.71 | 802.81 | 794.69 | 733.14 | -477.27 | -816.54 | 658.12 | 497.69 | 366.70 | 573.21 | |
| Debt/EBITDA | - - | -0.16 | -0.56 | 140.25 | 78.16 | 158.76 | 277.94 | 300.22 | 253.00 | 405.27 | 194.30 | 1,117.13 | 253.12 | 203.39 | 257.36 | |
|
Debt/Capitalization
|
- - | - - | - - | 82.33 | 76.62 | 89.60 | 88.92 | 88.82 | 88.00 | 126.51 | 113.96 | 86.81 | 83.27 | 78.57 | 85.15 | |
| Long-Term Debt/Capitalization | - - | - - | - - | 81.31 | 76.09 | 85.85 | 88.11 | 88.71 | 85.86 | 131.80 | 114.91 | 85.57 | 80.64 | 77.41 | 83.44 | |
| Interest Debt per Share USD | - - | - - | - - | 10.00 | 9.44 | 9.66 | 19.91 | 23.31 | 24.04 | 26.90 | 46.07 | 52.99 | 44.67 | 36.99 | 34.53 | |
| Debt Growth | - - | - - | - - | - - | -6.06 | 1.96 | 110.99 | 16.33 | 1.43 | 7.87 | 65.54 | 28.97 | -10.89 | -17.49 | -6.14 | |
| Liquidity | ||||||||||||||||
| Current Ratio | - - | 218.50 | 124.72 | 226.59 | 259.46 | 141.12 | 149.75 | 165.49 | 127.53 | 98.29 | 317.74 | 84.34 | 79.35 | 96.36 | 87.21 | |
| Quick Ratio | - - | 89.97 | 75.82 | 181.14 | 213.66 | 111.10 | 120.59 | 114.31 | 89.40 | 77.99 | 291.00 | 60.36 | 56.28 | 69.34 | 63.35 | |
| Cash Ratio | - - | 0.26 | 0.47 | 87.09 | 139.48 | 73.23 | 77.10 | 52.14 | 55.90 | 42.28 | 256.17 | 29.48 | 27.69 | 31.15 | 33.86 | |
| Operating Cash Flow Ratio | - - | 100 | 100 | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Turnover | ||||||||||||||||
| Inventory Turnover | - - | 513.35 | 532.30 | 413.20 | 398.35 | 393.77 | 261.78 | 403.95 | 438.63 | 480.87 | 410.31 | 464.86 | 557.74 | 486.56 | 214.20 | |
| Receivables Turnover | - - | 463.61 | 456.95 | 427.64 | 391.21 | 465.16 | 483.28 | 538.84 | 554.56 | 608.34 | 612.86 | 519.20 | 563.27 | 515.85 | 486.94 | |
| Payables Turnover | - - | 1,203.25 | 1,112.48 | 810.79 | 491.00 | 502.38 | 281.78 | 414.57 | 477.61 | 499.22 | 512.33 | 676.05 | 605.34 | 593.52 | 238.07 | |
|
Asset Turnover
|
- - | 73.99 | 88.74 | 68.05 | 64.35 | 72.46 | 43.09 | 38.79 | 39.86 | 55.18 | 37.33 | 30.42 | 38.35 | 41.82 | 40.32 | |
| Fixed Turnover | - - | 663.31 | 813.54 | 817.98 | 817.67 | 803.22 | 891.19 | 984.56 | 1,006.64 | 1,136.07 | 1,123.09 | 872.79 | 1,099.75 | 1,176.37 | 1,088.76 | |
| Coverage | ||||||||||||||||
| Interest Coverage | - - | - - | - - | 5,593.27 | 2,037.41 | 872.38 | 1,098.69 | 972.44 | 955.38 | 557.95 | 860.37 | 20.88 | 751.85 | 812.42 | 1,044.04 | |
| Asset Coverage | - - | - - | - - | 100 | 100 | 100 | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Cash Flow Coverage (CFGR) | - - | - - | - - | 40.49 | 42.57 | 23.64 | 23.79 | 19.11 | 26.65 | 33.31 | 19.97 | 20.44 | 29.70 | 39.42 | 38.46 | |
| EBITDA Coverage | - - | - - | - - | 6,600 | 2,300 | 1,000 | 1,200 | 1,000 | 1,100 | 700 | 900 | 300 | 1,100 | 1,100 | 1,000 | |
| Dividend Coverage | - - | - - | - - | - - | -100 | - - | -100 | -100 | -100 | -100 | -100 | - - | -100 | -100 | - - | |
| Time Interest Earned (TIE) | 200 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 200 | 100 | 100 | 100 | 100 | |
| Market Prospects | ||||||||||||||||
| Dividend Yield | - - | - - | - - | - - | 3.04 | 2.55 | 3.42 | 3.66 | 2.66 | 3.93 | 4.85 | 4.32 | 3.86 | 3.51 | 3.85 | |
| Earnings Yield | 8.20 | 7.39 | 6.07 | 9.79 | 4.92 | 1.70 | 5.34 | 5.86 | 3.44 | 4.00 | 6.01 | 2.58 | 4.82 | 4.14 | 1.78 | |
|
Price/Earnings (P/E)
|
1,219.88 | 1,353.76 | 1,647.48 | 1,021.24 | 2,032.83 | 5,883.70 | 1,871.40 | 1,706.19 | 2,907.31 | 2,498.06 | 1,663.64 | 3,869.56 | 2,076.40 | 2,418.14 | 5,634.11 | |
| Price/Earnings Growth (PEG) | - - | -138.76 | -90.79 | 17.60 | -88.44 | -103.26 | 10.18 | 107.49 | -312.11 | 217.59 | 38.13 | -79.80 | 15.12 | 921.74 | -95.58 | |
|
Price/Book (P/B)
|
- - | 360.19 | 462.71 | 1,601.85 | 1,868.10 | 5,991.78 | 2,440.18 | 2,190.89 | 3,028.24 | -1,682.04 | -1,604.60 | 1,366.01 | 1,555.41 | 1,658.81 | 2,644.66 | |
| Price/Tangible Book (P/TB) | - - | 360.19 | 462.71 | 1,601.85 | 1,868.10 | 5,991.78 | 2,440.18 | 2,190.89 | 3,028.24 | -1,682.04 | -1,604.60 | 1,366.01 | 1,555.41 | 1,658.81 | 2,644.66 | |
| Price/Sales (P/S) | 397.91 | 361.68 | 324.24 | 293.09 | 446.59 | 522.93 | 421.13 | 396.17 | 547.03 | 433.75 | 394.18 | 389.96 | 426.46 | 493.01 | 504.41 | |
|
Price/Cash Flow (P/CF)
|
1,053.78 | 1,136.66 | 905.40 | 849.02 | 1,339.00 | 2,941.02 | 1,277.57 | 1,442.55 | 1,549.69 | 1,058.05 | 984.15 | 1,015.57 | 1,052.19 | 1,147.46 | 1,199.65 | |
| Price/Free CF (P/FCF) | 1,118.94 | 1,249.12 | 960.04 | 896.05 | 1,452.82 | 3,553.86 | 1,374.63 | 1,547.85 | 1,636.61 | 1,110.84 | 1,026.68 | 1,063.84 | 1,089.85 | 1,180.35 | 1,241.90 | |
| Price/Operating CF (P/OCF) | 1,053.78 | 1,136.66 | 905.40 | 849.02 | 1,339.00 | 2,941.02 | 1,277.57 | 1,442.55 | 1,549.69 | 1,058.05 | 984.15 | 1,015.57 | 1,052.19 | 1,147.46 | 1,199.65 |